Ole Olesen, executive director of the European Vaccine Initiative (EVI), shares the highlights of his first nine months in the job grappling with a global pandemic; the mission of EVI to support the development of non-commercially viable vaccines as well as to create a European vaccine infrastructure; as well as his hopes for the future of the vaccine sector.
Whereas previously vaccines were a little out of fashion, and the sector was rather dusty and forgotten, now, people can see the importance of vaccine R&D quite clearly
